The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo

Cell

Volumn 111, Issue 1, 2002, Pages 41-50

  Fu, Loning ^a   Pelicano, Helene ^b   Liu, Jinsong ^b   Huang, Peng ^b   Lee, Cheng Chi ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER SUSCEPTIBILITY; CELL CYCLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; CYCLIN A GENE; CYCLIN D1 GENE; DNA DAMAGE; GADD45ALPHA GENE; GAMMA RADIATION; GENE; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSCRIPTION; IN VIVO STUDY; MDM 2 GENE; MPER2 GENE; NONHUMAN; PERIOD2 GENE; PRIORITY JOURNAL; THYMOCYTE;

ANIMALIA;

EID: 0037020198     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(02)00961-3     Document Type: Article

References (54)

1. Albrecht U., Sun Z.S., Eichele G., Lee C.C. A differential response of two putative mammalian circadian regulators, mPer1 and mPer2 to light. Cell. 91:1997;1055-1064.
2. Anderson L.E., Morris J.E., Sasser L.B., Stevens R.G. Effect of constant light on DMBA mammary tumorigenesis in rats. Cancer Lett. 148:2000;121-126.
3. Bae K., Jin X., Maywood E.S., Hastings M.H., Reppert S.M., Weaver D.R. Differential functions of mPer1, mPer2, and mPer3 in the SCN circadian clock. Neuron. 30:2001;525-536.
4. Balsalobre A., Damiola F., Schibler U. A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell. 93:1998;929-937.
5. Banks L., Matlashewski G., Crawford L. Isolation of human p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur. J. Biochem. 159:1986;529-534.
6. Barbason H., Herens C., Robaye B., Milis G., Sulon J., Bouzahzah B., VanCantfort J. Importance of cell kinetics rhythmicity for control of cell proliferation and carcinogenesis in rat liver. In Vivo. 9:1995;539-548.
7. Battey J., Moulding C., Taub R., Murphy W., Stewart T., Potter H., Lenoir G., Leder P. The human c-myc oncogene. structural consequences of translocation into the IgH locus in Burkitt lymphoma Cell. 34:1983;779-787.
8. Bjarnason G.A., Jordan R. Circadian variation of cell proliferation and cell cycle protein expression in man. clinical implications Prog. Cell Cycle Res. 4:2000;193-206.
9. Bjarnason G.A., Jordan R.C., Sothern R.B. Circadian variation in the expression of cell-cycle proteins in human oral epithelium. Am. J. Pathol. 154:1999;613-622.
10. Blackwell T.K., Huang J., Ma A., Kretzner L., Alt F.W., Eisenman R.N., Weintraub H. Binding of myc proteins to canonical and noncanonical DNA sequences. Mol. Cell. Biol. 13:1993;5216-5224.
11. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-258.
12. Chirgwin J.M., Przybyla A.E., MacDonald R.J., Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294-5299.
13. Clarke A.R., Purdie C.A., Harrison D.J., Morris R.G., Bird C.C., Hooper M.L., Wyllie A.H. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature. 362:1993;849-852.
14. Evan G.I., Vousden K.H. Proliferation, cell cycle and apoptosis in cancer. Nature. 411:2001;342-348.
15. Facchini L.M., Chen S., Marhin W.W., Lear J.N., Penn L.Z. The myc negative auto regulation mechanism requires Myc-Max association and involves the c-Myc p2 minimal promoter. Mol. Cell. Biol. 17:1997;100-114.
16. Fort P., Marty L., Piechaczyk M., Sabrouty S.E., Dani C., Jeanteur P., Blanchard J.M. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 13:1985;1431-1442.
17. Fu L., Benchimol S. Participation of the human p53 3′UTR in translational repression and activation following gamma-irradiation. EMBO J. 16:1997;4117-4125.
18. Gao C.F., Ren S., Zhang L., Nakajima T., Ichinose S., Hara T., Koike K., Tsuchida N. Caspase-dependent cytosolic release of cytochrome c and membrane translocation of Bax in p53-induced apoptosis. Exp. Cell Res. 265:2001;145-151.
19. Giaccia A.J., Kastan M.B. The complexity of p53 modulation. emerging patterns from divergent signals Genes Dev. 12:1998;2973-2983.
20. Green D.R., Reed J.C. Mitochondria and apoptosis. Science. 281:1998;1309-1312.
21. Hansen J. Increased breast cancer risk among women who work predominantly at night. Epidemiology. 12:2001;74-77.
22. Hecht J.L., Aster J.C. Molecular biology of Burkitt's lymphoma. J. Clin. Oncol. 18:2000;3707-3721.
23. Hrushesky W.J. Tumor chronobiology. J. Controlled Release. 74:2001;27-30.
24. Klevecz R.R., Shymko R.M., Blumenfeld D., Braly P.S. Circadian gating of S phase in human ovarian cancer. Cancer Res. 47:1987;6267-6271.
25. Kornmann B., Preitner N., Rifat D., Fleuury-Olela F., Schibler U. Analysis of circadian liver gene expression by ADDER, a highly sensitive method for the display of differentially expressed mRNAs. Nucleic Acids Res. 29:2001;E51.
26. Lee T.C., Ziff E.B. Mxi1 is a repressor of the c-myc promoter and reverses activation by USF. J. Biol. Chem. 274:1999;595-606.
27. Lowe S.W., Schmitt E.M., Smith S.W., Osborne B.A., Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature. 362:1993;847-849.
28. Matsushime H., Roussel M.F., Ashmun R.A., Sherr C.J. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell. 65:1991;701-713.
29. McNamara P., Seo S., Daniel R., Sehgal A., Chakravarti D., FitzGerald G.A. Regulation of CLOCK and MOP4 by nuclear hormone receptors in the vasculature. a humoral mechanism to reset a peripheral clock Cell. 105:2001;877-889.
30. Oliner J.D., Kinzler K.W., Meltzer P.S., George D.L., Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature. 358:1992;80-83.
31. Panda S., Antoch M.P., Miller B.H., Su A.I., Schook A.B., Straume M., Schultz P.G., Kay S.A., Takahashi J.S., Hogenesch J.B. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell. 109:2002;307-320.
32. Pelengaris S., Khan M., Evan G.I. Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progress. Cell. 109:2002;321-334.
33. Pucci B., Kasten M., Giordano A. Cell cycle and apoptosis. Neoplasia. 2:2000;291-299.
34. Reick M., Garcia J.A., Dudley C., McKnight S.L. NPAS2. an analog of clock operative in the mammalian forebrain Science. 293:2001;506-509.
35. Reppert S.M., Weaver D.R. Molecular analysis of mammalian circadian rhythms. Annu. Rev. Physiol. 63:2001;647-676.
36. Robertson E.J. Embryo-derived stem cell lines. Teratocarcinomas and Embryonic Stem Cells. A Practical Approach. J. Robertson:1987;IRL Press, Oxford. 71-112.pp.
37. Ruifrok A.C.C., Weil M.M., Thames H.D., Mason K.A. Diurnal variations in the expression of radiation-induced apoptosis. Radiat. Res. 149:1998;360-365.
38. Rutter J., Reick M., Wu L.C., McKnight S.L. Regulation of Clock and NPAS2 DNA binding by the redox state of NAD cofactors. Science. 293:2001;510-514.
39. Shearman L.P., Sriram S., Weaver D.R., Maywood E.S., Chaves I., Zheng B., Kume K., Lee C.C., van der Horst G.T., Hastings M.H., Reppert S.M. Interacting molecular loops in the mammalian circadian clock. Science. 288:2000;1013-1019.
40. Sheen J.H., Dickson R.B. Overexpression of c-Myc alters G(1)/S arrest following ionizing radiation. Mol. Cell. Biol. 22:2002;1819-1833.
41. Sherr C.J. Cancer cell cycles. Science. 274:1996;1672-1677.
42. Spencer C.A., Groudine M. Control of c-myc regulation in normal and neoplastic cells. Adv. Cancer Res. 56:1991;1-48.
43. Sun Z.S., Albrecht U., Zhuchenko O., Bailey J., Eichele G., Lee C.C. RIGUI, a putative mammalian ortholog of the Drosophila period gene. Cell. 90:1997;1003-1011.
44. Toh K.L., Jones C.R., He Y., Eide E.J., Hinz W.A., Virshup D.M., Ptacek L.J., Fu Y.H. An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science. 291:2001;1040-1043.
45. Vafa O., Wade M., Kern S., Beeche M., Pandita T.K., Hampton G.M., Wahl G.M. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function. A mechanism for ontogeny-induced genetic instability. Mol. Cell. 9:2002;1031-1044.
46. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature. 408:2000;307-310.
47. Winningham M.L. Strategies for managing cancer-related fatigue syndrome. a rehabilitation approach Cancer. 92(suppl 4):2001;988-997.
48. Wood P.A., Hrushesky W.J., Klevecz R. Distinct circadian time structures characterize myeloid and erythroid progenitor and multipotential cell clonogenicity as well as marrow precursor proliferation dynamics. Exp. Hematol. 26:1998;523-533.
49. Yamaguchi S., Mitsui S., Miyake S., Yan L., Onishi H., Yagita K., Suzuki M., Shibata S., Kobayashi M., Okamura H. The 5′ upstream region of mPer1 gene contains two promoters and is responsible for circadian oscillation. Curr. Biol. 10:2000;873-876.
50. You Z., Saims D., Chen S., Zhang Z., Guttridge D.C., Guan K.L., MacDougald O.A., Brown A.M., Evan G., Kitajewski J., Wang C.Y. Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis. J. Cell Biol. 157:2002;429-440.
51. Young M.W., Kay S.A. Time zones. a comparative genetics of circadian clocks Nat. Rev. Genet. 2:2001;702-715.
52. Zheng B., Larkin D.W., Albrecht U., Sun Z.S., Sage M., Eichele G., Lee C.C., Bradeley A. The mPer2 gene encodes a functional component of the mammalian circadian clock. Nature. 400:1999;169-173.
53. Zheng B., Albrecht U., Kaasik K., Sage M., Lu W., Vaishnav S., Li Q., Sun Z.S., Eichele G., Bradley A., Lee C.C. Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. Cell. 105:2001;683-694.
54. Zylka M.J., Shearman L.P., Weaver D.R., Reppert S.M. Three period homologs in mammals. differential light responses in the suprachiasmatic circadian clock and oscillating transcripts outside of brain Neuron. 20:1998;1103-1110.